Patents Assigned to AFIMMUNE LIMITED
  • Compositions comprising 15-HEPE and methods of using the same
    Patent number: 10813903
    Abstract: The present invention relates to the compositions, formulations and methods of treating fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) and their sequelae by administration of 15-OHEPA.
    Type: Grant
    Filed: July 31, 2019
    Date of Patent: October 27, 2020
    Assignee: Afimmune Limited
    Inventors: Jonathan Rowe, Kevin Duffy, John Climax
  • Compositions comprising 15-HEPE and methods of treating or preventing cancer and neurologic disease
    Patent number: 10716773
    Abstract: The present disclosure provides compositions comprising 15-HEPE and methods of using same for treating and/or preventing cancer and neurological diseases in a subject in need thereof.
    Type: Grant
    Filed: January 25, 2018
    Date of Patent: July 21, 2020
    Assignee: Afimmune Limited
    Inventors: John Climax, David Coughlan
  • Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
    Patent number: 10363235
    Abstract: The present disclosure provides compositions comprising 15-HEPE and methods of using same for treating and/or preventing fibrosis in a subject in need thereof.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: July 30, 2019
    Assignee: Afimmune Limited
    Inventors: Jonathan Rowe, Kevin Duffy, John Climax
  • Compositions comprising 15-HEPE and methods of using the same
    Patent number: 10231945
    Abstract: The present invention relates to the compositions comprising 15-HEPE and methods of treatment relating to same.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: March 19, 2019
    Assignee: Afimmune Limited
    Inventors: David Coughlan, John Climax
  • Compositions comprising 15-HEPE and methods of using the same
    Patent number: 9855238
    Abstract: The present invention relates to the compositions comprising 15-HEPE and methods of treatment relating to same.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: January 2, 2018
    Assignee: AFIMMUNE LIMITED
    Inventors: David Coughlan, John Climax